Abstracts tagged "Total joint replacement"

Abstract Number: 1470 • ACR Convergence 2020
Machine Learning-Based Prediction of Knee Replacement in Persons with and Without Radiographic Osteoarthritis Using Clinical and Imaging Features of Osteoarthritis: The Multicenter Osteoarthritis Study
S. Reza Jafarzadeh¹, David Felson¹, Michael Nevitt², James Torner³, Cora Lewis⁴, Frank Roemer⁵, Ali Guermazi¹ and Tuhina Neogi¹, ¹Boston University School of Medicine, Boston, MA, ²University of California, San Francisco, San Francisco, CA, ³University of Iowa, Iowa City, IA, ⁴University of Alabama Birmingham, Birmingham, AL, ⁵Boston University School of Medicine, Boston, MA, and Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany, Erlangen, Germany
Background/Purpose: Prior studies of predictors of knee replacement (KR) have often included only a limited set of risk factors, been conducted primarily in knees with…
Abstract Number: 1652 • ACR Convergence 2020
Progression of Knee OA with Use of Intra-articular Corticosteroids (CS) vs Hyaluronic Acid (HA)
Justin Bucci¹, Xiaoyang Chen¹, James Torner², Michael Nevitt³, Cora Lewis⁴ and David Felson⁵, ¹Boston University, Boston, MA, ²University of Iowa, Iowa City, IA, ³University of California, San Francisco, Orinda, CA, ⁴University of Alabama Birmingham, Birmingham, AL, ⁵Boston University School of Medicine, Boston, MA
Background/Purpose: Recent studies have questioned whether CS injections (CSI), a popular treatment recommended by guidelines, hasten progression of knee OA. A recent cohort study suggested…
Abstract Number: 1653 • ACR Convergence 2020
Bilateral vs Unilateral Total Knee Arthroplasty: Racial Variation in Utilization and In-Hospital Major Complication Rates
Bella Mehta¹, Kaylee Ho², Jennifer Bido³, Stavros Memtsoudis³, Michael Parks⁴, Susan Goodman¹, Linda Russell⁵ and Said Ibrahim⁶, ¹Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, ²Weill Cornell Medicine, New York, ³Hospital for Special Surgery, New York, ⁴Hospital for Special Surgery, Weill Cornell Medicine, New York, ⁵Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ⁶Weill Cornell Medicine, Cleveland, OH
Background/Purpose: Compared to White Patients, African Americans (AAs) are reported to have lower utilization and higher complication rates outcomes in Unilateral Total knee arthroplasty (UTKA).…
Abstract Number: 1654 • ACR Convergence 2020
The Relationship Between Patient-Reported Readiness for Total Knee Arthroplasty and the Likelihood of a Good Outcome at One Year
Gillian Hawker¹, Barbara Conner-Spady², Eric Bohm³, Michael Dunbar⁴, Allyson Jones⁵, Bheeshma Ravi¹, Tom Noseworthy², Linda Woodhouse⁶, Peter Faris⁷, Donald Dick⁸, James Powell², Paulose Paul⁵ and Deborah Marshall², ¹University of Toronto, Toronto, ON, Canada, ²University of Calgary, Calgary, AB, Canada, ³Concordia Hip & Knee Institute, University of Manitoba, Winnipeg, MB, Canada, ⁴Dalhousie University, Halifax, NS, Canada, ⁵University of Alberta, Edmonton, AB, Canada, ⁶Curtin University, Perth, Western Australia, Australia, ⁷Alberta Health Services, Calgary, ON, Canada, ⁸Alberta Bone and Joint Health Institute, Edmonton, AB, Canada
Background/Purpose: In prior qualitative research, we found that patients with knee osteoarthritis (OA) equated appropriateness for total knee arthroplasty (TKA) with candidacy for the procedure.…
Abstract Number: 415 • 2019 ACR/ARP Annual Meeting
Validation of a Satisfaction Measure for Use in Total Joint Replacement Clinical Trials
Susan Goodman¹, Bella Mehta ², Cynthia Kahlenberg ³, Jackie Finik ⁴, Mark Figgie ⁵, Michael Parks ², Douglas Padgett ³, Vinicius Antao ³, Adolf Yates ⁶, Bryan Springer ⁷, Stephen Lyman ³ and Jasvinder Singh ⁸, ¹Hospital For Special Surgery/Weill Cornell Medicine, New York, NY, ²Hospital for Special Surgery/Weill Cornell Medicine, New York, ³Hospital for Special Surgery, New York, ⁴Hospital for Special Surgery, New York, NY, New York, NY, ⁵Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, New York, NY, ⁶University of Pittsburgh School of Medicine Shadyside, Pittsburgh, ⁷OrthoCarolina Hip and Knee Center, Charlotte, ⁸University of Alabama Medical Center, Birmingham
Background/Purpose: Patient satisfaction after total hip (THR) and total knee replacement (TKR) is a core outcome selected by the Outcomes Measurement in Rheumatology (OMERACT), yet…
Abstract Number: 1306 • 2019 ACR/ARP Annual Meeting
Risk Factors for Pain After Total Joint Replacement in Osteoarthritis: Different Pain Measures, Distinct Predictors?
Joana Barroso¹, Kenta Wakaizumi ², Thomas Schnitzer ¹, Vasco Galhardo ³ and Apkar Apkarian ¹, ¹Northwestern University Feinberg School of Medicine, Chicago, IL, ²Northwestern University, Chicago, IL, ³Porto University, Porto, Portugal
Background/Purpose: Prognostic factors for pain persistence after total joint replacement (TJR) in osteoarthritis (OA) have been repeatedly proposed. These factors are commonly considered to act…
Abstract Number: 2162 • 2019 ACR/ARP Annual Meeting
Characteristics of Patients with Rheumatoid Arthritis Undergoing Primary Total Joint Replacement: A 14-year Trend Analysis (2004-2017)
Shuji Asai¹, Toshihisa Kojima ¹, Nobunori Takahashi ¹ and Naoki Ishiguro ¹, ¹Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
Background/Purpose: Total joint replacement (TJR) is performed when severe large joint destruction causes functional disability in patients with rheumatoid arthritis (RA). Biologics were approved in…
Abstract Number: 2300 • 2019 ACR/ARP Annual Meeting
Risk Factors for Transfusion and Use of Tranexemic Acid in Patients with Rheumatoid Arthritis Undergoing Total Hip Arthroplasty and Total Knee Arthroplasty
Kyle Morse ¹, Jeremy Abolade ¹, Nicole Heinz ¹, Meng Zhang ², Linda Russell ¹, Serene Mirza ¹, Dana Orange ³, Joshua Wright-Chisem ¹, Mark Figgie ⁴, Peter Sculco ¹ and Susan Goodman⁵, ¹Hospital for Special Surgery, New York, ²The Feinstein Institute for Medical Research, Northwell Health, Manhasset, ³Rockefeller University, New York, ⁴Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, New York, NY, ⁵Hospital For Special Surgery/Weill Cornell Medicine, New York, NY
Background/Purpose: Utilization of total hip (THA) and total knee arthroplasty (THA) remains high for patients with RA, and most patients have moderate to high disease…
Abstract Number: 1084 • 2012 ACR/ARHP Annual Meeting
In Vivo Kinematics of Three-Component Mobile-Bearing Total Ankle Replacement for Rheumatoid Arthritis
Keiji Iwamoto¹, Tetsuya Tomita², Takaharu Yamazaki³, Kenrin Shi⁴, Norimasa Shimizu¹, Masahiro Kurita¹, Kazuma Futai¹, Yasuo Kunugiza⁵, Hideki Yoshikawa⁶ and Kazuomi Sugamoto¹, ¹Orthopedic Biomaterial Science, Osaka University Graduate School of Medicine, Osaka, Japan, ²Dept of Orthopaedics, Osaka University Graduate School of Medicine, Osaka, Japan, ³The Center for Advanced Medical Engineering and Informatics, Osaka University, Osaka, Japan, ⁴Orthopaedic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan, ⁵Orthopedics, Osaka University Graduate School of Medicine, Osaka, Japan, ⁶Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Japan
Background/Purpose: The standard treatment for end-stage arthritis of the ankle joint due to rheumatoid arthritis (RA) has been an ankle arthrodesis. Patients with RA who…
Abstract Number: 909 • 2012 ACR/ARHP Annual Meeting
Determinants of Patient Preferences for Total Knee Replacement: A Comparison of Whites and African-Americans
C. Kent Kwoh¹, Robert M. Boudreau², Yona Cloonan³, Michael J. Hannon⁴, Ernest R. Vina⁵ and Said Ibrahim⁶, ¹School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ²Epidemiology, University of Pittsburgh, Pittsburgh, PA, ³Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, ⁴Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, ⁵Division of Rheumatology and Clinical Immunology, University of Pittsburgh and VA Pittsburgh Healthcare System, Pittsburgh, PA, ⁶Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
Background/Purpose: TKR is a cost-effective treatment option for end-stage knee osteoarthritis (OA). Although it is one of the fastest growing elective surgeries, there are marked…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].